State OK
Clinical Trials in Oklahoma
Recruiting clinical trials with at least one study location in Oklahoma. Data updated daily from ClinicalTrials.gov.
Top Conditions in Oklahoma
Malignant Solid Neoplasm (6)Ovarian Cancer (5)Endometrial Cancer (5)Breast Cancer (4)Colorectal Cancer (4)Melanoma (3)Major Depressive Disorder (3)Anatomic Stage IV Breast Cancer AJCC v8 (3)Clinical Stage III Gastric Cancer AJCC v8 (3)Clinical Stage IV Gastric Cancer AJCC v8 (3)Lung Non-Small Cell Carcinoma (2)Sarcoma (2)
NCT05040360 Phase 2
Recruiting
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendo...
Condition
Metastatic Malignant Neoplasm in the Liver
Enrollment
141 pts
Location
United States, Mexico, Uruguay
Sponsor
SWOG Cancer Research Network
NCT07283939 N/A
Recruiting
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned...
Condition
Ampulla of Vater Carcinoma
Enrollment
420 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT04965675 Phase 3
Recruiting
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Condition
Chronic Migraine in Children
Enrollment
285 pts
Location
United States, Argentina, Canada
Sponsor
H. Lundbeck A/S
NCT05633654 Phase 3
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physic...
Condition
Triple Negative Breast Cancer
Enrollment
1,514 pts
Location
United States, Australia, France
Sponsor
Gilead Sciences
NCT06295367 N/A
Recruiting
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Condition
Malignant Solid Neoplasm
Enrollment
760 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT05053971 Phase 1, Phase 2
Recruiting
Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanc...
Condition
Advanced Malignant Solid Neoplasm
Enrollment
49 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT04550494 Phase 2
Recruiting
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Re...
Condition
Anatomic Stage III Breast Cancer AJCC v8
Enrollment
36 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05757102 Phase 3
Recruiting
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/V...
Condition
Asthma
Enrollment
292 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
NCT04928508 Phase 1
Recruiting
Advanced or Recurrent Solid Tumors Treated With SHetA2
Condition
Solid Tumor, Adult
Enrollment
50 pts
Location
United States
Sponsor
University of Oklahoma
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
NCT07327489 N/A
Recruiting
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies
Condition
Cancer
Enrollment
2,000 pts
Location
United States
Sponsor
Elephas
NCT01766297 Phase 2
Recruiting
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stag...
Condition
Breast Cancer
Enrollment
132 pts
Location
United States
Sponsor
Proton Collaborative Group
NCT06389136 Phase 3
Recruiting
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Der...
Condition
Atopic Dermatitis
Enrollment
200 pts
Location
United States, Canada, Colombia
Sponsor
AbbVie
NCT05836987 Phase 3
Recruiting
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial F...
Condition
Atrial Fibrillation
Enrollment
5,350 pts
Location
United States
Sponsor
Johns Hopkins University
NCT06914908 Phase 2
Recruiting
Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants Wit...
Condition
Chronic Rhinosinusitis With Nasal Polyps
Enrollment
64 pts
Location
United States, Argentina, Belgium
Sponsor
Sanofi
NCT06475989 Phase 3
Recruiting
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Condition
Refractory Differentiated Thyroid Gland Carcinoma
Enrollment
264 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT06345690 N/A
Recruiting
VIA Disc NP Registry 3.0
Condition
Discogenic Pain
Enrollment
500 pts
Location
United States
Sponsor
VIVEX Biologics, Inc.
NCT05440708 Phase 1, Phase 2
Recruiting
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locall...
Condition
Hepatocellular Carcinoma
Enrollment
178 pts
Location
United States
Sponsor
Tvardi Therapeutics, Incorpora
NCT07184996 Phase 3
Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Partic...
Condition
Ulcerative Colitis
Enrollment
980 pts
Location
United States, Canada, Japan
Sponsor
Sanofi
NCT06498635 Phase 3
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After ...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
306 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05412927 N/A
Recruiting
AngelMed Guardian® System PMA Post Approval Study
Condition
Acute Coronary Syndrome
Enrollment
500 pts
Location
United States
Sponsor
Angel Medical Systems
NCT03493425 Phase 2
Recruiting
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Thera...
Condition
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
Enrollment
82 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT03435796 Phase 2, Phase 3
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Condition
Neoplasms
Enrollment
1,541 pts
Location
United States, Australia, Austria
Sponsor
Celgene
NCT03907046 Phase 3
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Condition
Intracerebral Hemorrhage
Enrollment
700 pts
Location
United States
Sponsor
Yale University
NCT04751331 Phase 1, Phase 2
Recruiting
Neural Response to Inflammatory Challenge in Major Depressive Disorder
Condition
Major Depressive Disorder
Enrollment
180 pts
Location
United States
Sponsor
Laureate Institute for Brain R